CD27 and systemic sclerosis: Flow cytometry analysis showed significantly higher levels of both circulating CD138+ CD38high plasma cells (1.9% vs 0.3%, p<0.001) and CD27+ CD38high plasmablasts (0.3% vs 0.1%, p<0.001) in SSc patients compared to HC (Figures 2C, D).